PATHOPHYSIOLOGY CLINICAL MANIFESTATIONS AND THERAPY OF CONSUMPTION-COAGULOPATHY (VERBRAUCHSKOAGULOPATHIE)

[1] Apitz K, 1935, J IMMUNOL, V29, P255

[2] THE HAEMOSTATIC BALANCE [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1958, 2 (3-4): : 347 - 357

[3] BETTEX-GALLAND M., 1965, ADVANCE PROTEIN CHEM, V20, P1, DOI 10.1016/S0065-3233(08)60387-3

[4] BOHLE A, 1959, 1 INT S IMM BAS, P339

[5] ENCKE A, UNPUBLISHED DATA

[6] FINE J, 1961, FED PROC, V20, P166

[7] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) : 896 - &

[8] PREVENTION OF IRREVERSIBLE HEMORRHAGIC SHOCK WITH FIBRINOLYSIN [J]. ANNALS OF SURGERY, 1963, 157 (01) : 39 - &

[9] HARDAWAY RM, 1966, SYNDROMES DISSEMINAT

[10] HARDAWAY RM, 1966, DIFFUSE INTRAVASCULA, P121

[1] Apitz K, 1935, J IMMUNOL, V29, P255

[2] THE HAEMOSTATIC BALANCE [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1958, 2 (3-4): : 347 - 357

[3] BETTEX-GALLAND M., 1965, ADVANCE PROTEIN CHEM, V20, P1, DOI 10.1016/S0065-3233(08)60387-3

[4] BOHLE A, 1959, 1 INT S IMM BAS, P339

[5] ENCKE A, UNPUBLISHED DATA

[6] FINE J, 1961, FED PROC, V20, P166

[7] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) : 896 - &

[8] PREVENTION OF IRREVERSIBLE HEMORRHAGIC SHOCK WITH FIBRINOLYSIN [J]. ANNALS OF SURGERY, 1963, 157 (01) : 39 - &

[9] HARDAWAY RM, 1966, SYNDROMES DISSEMINAT

[10] HARDAWAY RM, 1966, DIFFUSE INTRAVASCULA, P121